English Spanish Chinese Russian German French Japanese Hindi Telugu Tamil

Jornal de Neurologia e Neurociência

  • ISSN: 2171-6625
  • Índice h do diário: 17
  • Pontuação de citação de diário: 4.43
  • Fator de impacto do periódico: 3.38
Indexado em
  • Abra o Portão J
  • Genamics JournalSeek
  • O Fator de Impacto Global (GIF)
  • Infraestrutura Nacional de Conhecimento da China (CNKI)
  • Diretório de Indexação de Periódicos de Pesquisa (DRJI)
  • OCLC- WorldCat
  • Invocação Proquest
  • Fator de Impacto de Revista Científica (SJIF)
  • Euro Pub
  • Google Scholar
  • Laboratórios secretos do mecanismo de pesquisa
Veja mais
Compartilhe esta página

Abstrato

Bradykinic-Mediated Angioedema Related to Alteplase Successfully Treated by Frozen Fresh Plasma (FFP) in Saudi Arabia: A First Case Report and Literature Review

Narjes M*, Sana K,  Neveen F, Bashir I, Hani K, Hassen M and Ahmed M

Angioedema can be a life-threatening complication after thrombolytic therapy (tPA). The incidence is 1-5%, the risk of developing bradykinin-mediated angioedema is multiplied by 6 in patient on angiotensin converting enzyme inhibitor. Most therapeutic options are ineffective or expensive and not available. FFP is known as effective treatment for bradykinin-mediate angioedema since 1969 but never reported in case of angioedema tPA induced. We report a case of 60year old patient with history of hypertension treated with angiotensin converting enzyme inhibitor, who developing severe bradykinin-mediates angioedema 10 min after the end of thrombolytic therapy. The patient was treated successfully with FFP. We are reporting this case to increase the awareness of physicians and to widen their therapeutic options when encountering this clinically significant condition.